Amarin Corp PLC (AMRN)
0.8704
+0.01
(+1.20%)
USD |
NASDAQ |
Apr 26, 15:29
Amarin Net Income (Quarterly): -5.781M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.781M |
| September 30, 2023 | -19.31M |
| June 30, 2023 | -17.56M |
| March 31, 2023 | -16.46M |
| December 31, 2022 | 0.856M |
| September 30, 2022 | -5.14M |
| June 30, 2022 | -69.96M |
| March 31, 2022 | -31.56M |
| December 31, 2021 | 14.70M |
| September 30, 2021 | -13.15M |
| June 30, 2021 | 7.808M |
| March 31, 2021 | -1.626M |
| December 31, 2020 | 4.926M |
| September 30, 2020 | -6.788M |
| June 30, 2020 | 4.415M |
| March 31, 2020 | -20.55M |
| December 31, 2019 | 7.068M |
| September 30, 2019 | -3.462M |
| June 30, 2019 | -1.82M |
| March 31, 2019 | -24.43M |
| December 31, 2018 | -33.67M |
| September 30, 2018 | -24.47M |
| June 30, 2018 | -34.21M |
| March 31, 2018 | -24.10M |
| December 31, 2017 | -22.46M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.82M |
| June 30, 2017 | -13.63M |
| March 31, 2017 | -20.94M |
| December 31, 2016 | -27.45M |
| September 30, 2016 | -15.77M |
| June 30, 2016 | -13.35M |
| March 31, 2016 | -29.77M |
| December 31, 2015 | -21.89M |
| September 30, 2015 | -30.68M |
| June 30, 2015 | -31.51M |
| March 31, 2015 | -31.13M |
| December 31, 2014 | -19.66M |
| September 30, 2014 | -26.05M |
| June 30, 2014 | 15.32M |
| March 31, 2014 | -25.98M |
| December 31, 2013 | -15.41M |
| September 30, 2013 | -48.88M |
| June 30, 2013 | -39.77M |
| March 31, 2013 | -62.16M |
| December 31, 2012 | -10.57M |
| September 30, 2012 | -26.43M |
| June 30, 2012 | -53.90M |
| March 31, 2012 | -88.28M |
| December 31, 2011 | 18.34M |
| September 30, 2011 | 96.34M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-69.96M
Minimum
Jun 2022
14.70M
Maximum
Dec 2021
-9.126M
Average
-5.14M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| Trinity Biotech PLC | -6.721M |
| DBV Technologies SA | -11.19M |
| Adaptimmune Therapeutics PLC | -47.92M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 74.71M |
| Total Expenses (Quarterly) | 79.32M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 24.55M |
| Gross Profit Margin (Quarterly) | 60.40% |
| Profit Margin (Quarterly) | -7.74% |
| Earnings Yield | -17.23% |
| Normalized Earnings Yield | -14.25 |